Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dmitry B Veprintsev

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
Nature Communications|April 19, 2017
A new inhibitor of the β-arrestin/AP2 endocytic complex reveals interplay between GPCR internalization and signallingAlexandre Beautrait, Justine S Paradis, Brandon Zimmerman, et al.
Nature Communications|January 8, 2025
Structural basis of THC analog activity at the Cannabinoid 1 receptorThor S Thorsen, Yashraj Kulkarni, David A Sykes, et al.
Pharmacology Research & Perspectives|August 27, 2022
Combined docking and machine learning identify key molecular determinants of ligand pharmacological activity on β2 adrenoceptorMireia Jiménez-Rosés, Bradley Angus Morgan, Maria Jimenez Sigstad, et al.
Nature Communications|March 21, 2019
Distinct G protein-coupled receptor phosphorylation motifs modulate arrestin affinity and activation and global conformationDaniel Mayer, Fred F Damberger, Mamidi Samarasimhareddy, et al.
Cell|March 4, 2014
Hsp90-Tau complex reveals molecular basis for specificity in chaperone actionG Elif Karagöz, Afonso M S Duarte, Elias Akoury, et al.
Journal of the American Chemical Society|July 4, 2023
Platform Reagents Enable Synthesis of Ligand-Directed Covalent Probes: Study of Cannabinoid Receptor 2 in Live CellsMiroslav Kosar, David A Sykes, Alexander E G Viray, et al.
Nature Communications|June 11, 2025
Multiple intramolecular triggers converge to preferential G protein coupling in the CB<sub>2</sub>RAdrian Morales-Pastor, Tamara Miljuš, Miguel Dieguez-Eceolaza, et al.
Journal of Medicinal Chemistry|July 11, 2024
Highly Selective Drug-Derived Fluorescent Probes for the Cannabinoid Receptor Type 1 (CB<sub>1</sub>R)Leonard Mach, Anahid Omran, Jara Bouma, et al.
Frontiers in Pharmacology|April 24, 2025
A universal cannabinoid CB1 and CB2 receptor TR-FRET kinetic ligand-binding assayLeire Borrega-Roman, Bradley L Hoare, Miroslav Kosar, et al.
ACS Central Science|May 27, 2024
Flipping the GPCR Switch: Structure-Based Development of Selective Cannabinoid Receptor 2 Inverse AgonistsMiroslav Kosar, Roman C Sarott, David A Sykes, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Nature Communications|April 19, 2017
A new inhibitor of the β-arrestin/AP2 endocytic complex reveals interplay between GPCR internalization and signallingAlexandre Beautrait, Justine S Paradis, Brandon Zimmerman, et al.
Nature Communications|January 8, 2025
Structural basis of THC analog activity at the Cannabinoid 1 receptorThor S Thorsen, Yashraj Kulkarni, David A Sykes, et al.
Pharmacology Research & Perspectives|August 27, 2022
Combined docking and machine learning identify key molecular determinants of ligand pharmacological activity on β2 adrenoceptorMireia Jiménez-Rosés, Bradley Angus Morgan, Maria Jimenez Sigstad, et al.
Nature Communications|March 21, 2019
Distinct G protein-coupled receptor phosphorylation motifs modulate arrestin affinity and activation and global conformationDaniel Mayer, Fred F Damberger, Mamidi Samarasimhareddy, et al.
Cell|March 4, 2014
Hsp90-Tau complex reveals molecular basis for specificity in chaperone actionG Elif Karagöz, Afonso M S Duarte, Elias Akoury, et al.
Journal of the American Chemical Society|July 4, 2023
Platform Reagents Enable Synthesis of Ligand-Directed Covalent Probes: Study of Cannabinoid Receptor 2 in Live CellsMiroslav Kosar, David A Sykes, Alexander E G Viray, et al.
Nature Communications|June 11, 2025
Multiple intramolecular triggers converge to preferential G protein coupling in the CB<sub>2</sub>RAdrian Morales-Pastor, Tamara Miljuš, Miguel Dieguez-Eceolaza, et al.
Journal of Medicinal Chemistry|July 11, 2024
Highly Selective Drug-Derived Fluorescent Probes for the Cannabinoid Receptor Type 1 (CB<sub>1</sub>R)Leonard Mach, Anahid Omran, Jara Bouma, et al.
Frontiers in Pharmacology|April 24, 2025
A universal cannabinoid CB1 and CB2 receptor TR-FRET kinetic ligand-binding assayLeire Borrega-Roman, Bradley L Hoare, Miroslav Kosar, et al.
ACS Central Science|May 27, 2024
Flipping the GPCR Switch: Structure-Based Development of Selective Cannabinoid Receptor 2 Inverse AgonistsMiroslav Kosar, Roman C Sarott, David A Sykes, et al.
Pageof 9